XBP1 has been implicated in several aspects of cancer biology, including tumor growth, metastasis, and resistance to therapy. Tumor cells often experience conditions that trigger ER stress, such as hypoxia and nutrient deprivation. By activating the UPR, XBP1 helps cancer cells adapt to these hostile conditions, promoting their survival and proliferation.